Provectus Algae is a technology company.
Provectus Algae has raised $21.0M across 2 funding rounds.
Provectus Algae has raised $21.0M in total across 2 funding rounds.
Provectus Algae has raised $21.0M in total across 2 funding rounds.
Provectus Algae's investors include At One Ventures, Hitachi Ventures.
Provectus Algae is a biotechnology company founded in 2018 that develops algae-based biomanufacturing solutions using its proprietary Precision Photosynthesis™ platform to produce sustainable products from microalgae, capturing carbon dioxide and light into high-value biochemicals, specialty ingredients, and biologics.[1][2][4] It primarily serves agriculture by creating Surf'N'Turf®, a stockfeed additive that reduces methane emissions from ruminant livestock (like cattle) by up to 95%, while also targeting food & beverage, cosmetics, therapeutics, aquaculture, and pharmaceuticals.[1][4][5] The company solves critical sustainability challenges, such as livestock's gigaton-scale greenhouse gas emissions and the need for scalable, carbon-negative biomanufacturing, with a modular, automated production system that enables localized manufacturing to minimize shipping and efficacy loss.[1][2][4] Growth momentum includes raising over $25M in funding and grants (including a $12.6M Series A in July 2025 led by At One Ventures), operating a 10-12KL pilot facility, scaling to a 30KL demonstration plant capable of 700+ daily doses (removing 4+ metric tons of CO2e/day), and planning a 160KL expansion plus a large-scale facility.[1][5]
Provectus Algae began in 2018 in a small, one-person laboratory in Noosaville, Australia, driven by the mission to harness microalgae's potential for sustainable biomanufacturing amid rising demands for carbon-negative solutions in agriculture and beyond.[1][4] The founders, leveraging expertise in downstream processing, formulation, synthetic biology, automation, and machine learning, identified the challenge of scaling algae production—particularly Asparagopsis seaweed for methane reduction in livestock—and developed Precision Photosynthesis™ to program microalgae for rapid, controlled production of bioactive compounds like bromoform (3.3x more than competitors at 5x faster growth rates).[2][4][5] Early traction came from building proprietary processes for consistent, high-quality algae biomass transformation into stable products, securing 4 patents, and launching the 10KL pilot operation, which evolved into partnerships and funding to support pivotal scaling milestones like the 30KL demonstration plant.[1][5]
Provectus Algae rides the photosynthetic biotech wave, capitalizing on microalgae's biochemical diversity, rapid growth, and carbon-capturing potential to disrupt heterotrophic-dominated biomanufacturing amid global net-zero pressures.[2][3] Timing aligns with surging demand for agriculture decarbonization—livestock methane accounts for gigaton-scale emissions—fueled by regulations, investor focus on climate tech, and market forces like rising feed costs and sustainability mandates.[1][4][5] By enabling scalable, localized algae production, it influences the ecosystem through partnerships (e.g., Unreasonable Impact), patents, and tech transfer, lowering barriers for industries to adopt carbon-negative alternatives and accelerating the shift to bio-based economies.[2][5]
Provectus Algae is poised for explosive growth, with its 160KL plant expansion and new large-scale facility targeting doses for 250,000+ animals by reducing over 500,000 metric tons of CO2e annually, building on $25M+ funding and recent Series A momentum.[1][5] Trends like AI-driven bioprocessing, policy-driven methane abatement, and demand for sustainable ingredients will propel it, potentially expanding Surf'N'Turf® globally while licensing its platform for new bioproducts. Its influence could evolve from livestock disruptor to foundational player in carbon-negative manufacturing, redefining profitability in animal agriculture and beyond—delivering on its promise to eliminate billions of tons of GHG emissions sustainably.[4]
Provectus Algae has raised $21.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in July 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2025 | $10.0M Series A | At One Ventures, Hitachi Ventures | |
| Dec 1, 2021 | $11.0M Seed | Hitachi Ventures |